To confirm whether the lncRNA HOTAIR-EZH2 interaction blocker EPIC and cPLA2 inhibitor AA could reduce ATP production in a more malignant GBM model, we repeated the ATP concentration measurement in cells with monotherapy or combination therapy. Here, PLA2G4A is linked to glioblastoma.